Subscriber access provided by STEPHEN F AUSTIN STATE UNIV
Article
Cationic phosphorus dendrimer enhances photodynamic activity of rose bengal against basal cell carcinoma cell lines Monika Dabrzalska, Anna Janaszewska, Maria Zablocka, Serge Mignani, Jean Pierre Majoral, and Barbara Klajnert-Maculewicz Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/acs.molpharmaceut.7b00108 • Publication Date (Web): 28 Mar 2017 Downloaded from http://pubs.acs.org on March 31, 2017
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Molecular Pharmaceutics is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
1
Cationic
phosphorus
dendrimer
enhances
2
photodynamic activity of rose bengal against basal
3
cell carcinoma cell lines
4
Monika Dabrzalska1, Anna Janaszewska1, Maria Zablocka2, Serge Mignani3, Jean Pierre
5
Majoral4,5, Barbara Klajnert-Maculewicz1,6*
6
1
7
University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland
8
2
9
112, 90-363 Lodz, Poland
Department of General Biophysics, Faculty of Biology and Environmental Protection,
Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza
10
3
11
Chimie et de Biochimie pharmacologiques et toxicologique, 45 rue des Saints Pères, 75006
12
Paris, France
13
4
Laboratoire de Chimie de Coordination CNRS, 205 route de Narbonne, 31077 Toulouse, France
14
5
Université de Toulouse, UPS, INPT, 31077, Toulouse Cedex 4, France
15
6
Leibniz-Institut für Polymerforschung Dresden e.V., Hohe Strasse 6, 01069 Dresden, Germany
16
* Corresponding author: Barbara Klajnert-Maculewicz, email:
[email protected] Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de
ACS Paragon Plus Environment
1
Molecular Pharmaceutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 2 of 45
17
KEYWORDS: phosphorus dendrimer, rose bengal, photosensitizer, photodynamic therapy,
18
basal cell carcinoma, phototoxicity.
19
ABSTRACT
20
In the last couple of decades, photodynamic therapy emerged as a useful tool in the treatment of
21
basal cell carcinoma. However, it still meets limitations due to unfavorable properties of
22
photosensitizers, such as poor solubility or lack of selectivity. Dendrimers - polymers widely
23
studied in biomedical field - may play a role as photosensitizer carriers and improve the efficacy
24
of photodynamic treatment. Here, we describe the evaluation of an electrostatic complex of
25
cationic phosphorus dendrimer and rose bengal in such aspects as singlet oxygen production,
26
cellular uptake and phototoxicity against three basal cell carcinoma cell lines. Rose bengal-
27
cationic dendrimer complex in molar ratio 5:1 was compared to free rose bengal. Obtained
28
results showed that the singlet oxygen production in aqueous medium was significantly higher
29
for the complex than for free rose bengal. The cellular uptake of the complex was 2-7-fold higher
30
compared to a free photosensitizer. Importantly, rose bengal, rose bengal-dendrimer complex and
31
dendrimer itself showed no dark toxicity against all three cell lines. Moreover, we observed that
32
phototoxicity of the complex was remarkably enhanced presumably due to high cellular uptake.
33
Based on the obtained results we conclude that rose bengal-cationic dendrimer complex has a
34
potential in photodynamic treatment of basal cell carcinoma.
35
36 37
ACS Paragon Plus Environment
2
Page 3 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
38
Molecular Pharmaceutics
1. INTRODUCTION
39
Basal cell carcinoma (BCC) is currently the most common type of skin cancer and has the
40
highest incidence among all type of cancers in Caucasians.1 The treatment of BCC cancer
41
is often based on surgical excision, although other therapies, such as photodynamic therapy
42
(PDT), may be applied as well.2 As PDT is rather a topical treatment method, it seems to be a
43
useful tool to treat topical diseases such as skin cancer, especially BCC tumors characterized by
44
very low rate of metastasis. Particularly, PDT offers excellent cosmetic outcomes.3-5
45
Photodynamic therapy has emerged as a treatment method nearly 40 years ago. This approach
46
is based on three elements: a photosensitizer (PS), molecular oxygen and visible light. The
47
mechanism of a photodynamic effect relies on a photosensitizer, which absorbs the energy after
48
illumination with a specific wavelength of visible light. This cause the excitation of PS from
49
the ground state (S0) to the first excited singlet state (S1). The excited photosensitizer can lose
50
the energy by fluorescence emission, conversion into heat or via intersystem crossing forming
51
long-lived excited triplet state (T1). A photosensitizer in an excited triplet state can react with
52
other molecules via two types of reactions. A Type I mechanism is based on reactions of
53
photosensitizer with surrounding substrates producing radicals and reactive oxygen species
54
(ROS). A Type II mechanism involves direct energy transfer between photosensitizer and the
55
molecular oxygen in ground state generating highly reactive singlet oxygen. Both types of
56
reactions lead to the oxidative stress and a cascade of reactions that ultimately cause cell death
57
(Scheme 1).6
ACS Paragon Plus Environment
3
Molecular Pharmaceutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 4 of 45
58 59
Scheme 1. Schematic representation of PDT mechanisms.
60
Although many compounds have been identified as photoactive, there are still few
61
photosensitizers approved in clinics. Unfortunately, the photodynamic therapy has a number of
62
limitations including poor PS solubility, lack of selectivity and prolonged sensitivity to light.
63
Hence, there is a need to improve the efficacy of photodynamic treatment.7 The challenge may
64
be achieved by designing drug delivery systems for photosensitizers to overcome above
65
mentioned disadvantages. Many different nanoparticles have been proposed as PS delivery
66
systems, e.g. liposomes,8,9 polymeric nanoparticles10 or silica nanoparticles.11 Among many
67
types of nanosystems, dendrimers have been proven to be promising platforms for drug delivery,
68
especially because of their regular, hyperbranched architecture, which specifically enables
69
several different ways to attach drug molecules to a carrier.12-14 PS molecules can be attached
70
either to the internal or surface groups. In addition, PS can be located at the core of the
ACS Paragon Plus Environment
4
Page 5 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
71
dendrimer, or it is possible to encapsulate PS molecules in internal cavities between dendrimer
72
branches.15 The majority of the studies on dendrimers as carriers of photosensitizers involved
73
porphyrins and phthalocyanines,16-20 and in one case authors demonstrated enhanced PDT
74
efficacy in vivo in comparison to clinically used PS –Photofrin®.21
75
Dendrimers may also deliver hydrophilic photosensitizers, such as 5-aminolewulinic acid (5-
76
ALA)22 or rose bengal.23 Rose bengal is a xanthene dye exhibiting high quantum yield of singlet
77
oxygen generation.24,25 It is a hydrophilic molecule with tendency to aggregate in aqueous
78
solutions. Therefore, the cellular uptake of rose bengal is often suppressed.26,27 It has a negative
79
impact on the reactive oxygen species generation and a cytotoxic effect caused by rose bengal.
80
Complexing rose bengal molecules with a dendrimer may significantly prevent the aggregation
81
of PS molecules. Moreover, an effective delivery of rose bengal through the cell membrane may
82
be enhanced by the use of a dendrimer as a nanocarrier of rose bengal molecules.
83
Recently we have prepared and characterized a dendrimer-photosensitizer complex using a
84
phosphorus dendrimer possessing cationic charges (1cat) and rose bengal (RB). Studies on the
85
interactions between RB and 1cat using Fourier transform infrared spectroscopy (FTIR)
86
demonstrated that 1cat formed a stable complex with RB molecules due to electrostatic
87
interactions. The stoichiometry of the complex RB:1cat was determined to be approximately 7:1.
88
We concluded that the cationic phosphorus dendrimer might be a promising candidate as a
89
carrier for RB.28,29 Therefore, it encouraged us to further investigation of the system in vitro.
90
The objective of this present study was to evaluate photodynamic activity of RB-1cat
91
dendrimer complex. We checked the ability of the complex to produce singlet oxygen in aqueous
92
environment and we compared a cellular uptake and phototoxicity of a free photosensitizer and
93
of the RB-1cat complex. As a biological model for the studies, we chose basal cell carcinoma
ACS Paragon Plus Environment
5
Molecular Pharmaceutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 6 of 45
94
cell lines. We used three long-term, murine basal cell carcinoma cell lines (ASZ, BSZ and CSZ)
95
that resemble the genetic features of human basal cell nevus syndrome and basal cell carcinoma
96
tumors.30
97
2. EXPERIMENTAL SECTION
98
2.1. Materials
99
Phosphorus dendrimer of the third generation possessing 48 ammonium surface groups
100
(referred as 1cat) was synthesized in the Laboratoire de Chimie de Coordination du CNRS.31
101
Rose bengal, Fetal Bovine Serum, Penicillin-Streptomycin solution, Trypsin-EDTA solution and
102
MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) were purchased from
103
Sigma-Aldrich. Dulbecco’s Phosphate Buffered Saline with no calcium and no magnesium
104
(DPBS) was purchased from Biowest. 154 CF culture medium was obtained from Gibco®.
105
Chelex® 100 Resin was obtained from Bio-Rad. Singlet Oxygen Sensor Green (SOSG) and
106
2’,7’- dichlorodihydrofluorescein diacetate (H2DCFDA) were purchased from Molecular
107
Probes™. SYTOX® Dead Cell Stain Kit and Trypan Blue Stain were obtained from
108
Invitrogen™. Dimethyl Sulphoxide (DMSO) was purchased from POCH (Poland). Annexin V-
109
fluorescein isothiocyanate (FITC) and binding buffer were obtained from BD Biosciences. The
110
structure of rose bengal (RB), 1cat dendrimer and schematic structure of the dendrimer is
111
depicted in Scheme 2.
ACS Paragon Plus Environment
6
Page 7 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
112 113
Scheme 2. Structures of the components used in this study: a) chemical structure of rose bengal
114
(RB); b) schematic structure of the cationic phosphorus dendrimer of third generation (1cat); c)
115
chemical structure of 1cat dendrimer.
116
2.2. Methods
117
2.2.1. Singlet Oxygen (1O2) generation in aqueous medium
118
To determine singlet oxygen production we used Singlet Oxygen Sensor Green reagent
119
(SOSG). SOSG is a commercially available, cell impermeable, fluorescent probe that is highly
120
selective for 1O2. SOSG was used in 1 µM concentration. All solutions of RB and RB-1cat
121
complex and 1cat were prepared in 10 mM DPBS buffer. Three concentrations of RB were used:
122
0.1, 0.25 and 0.5 µM. A molar ratio RB:1cat was 5:1. Respectively, the dendrimer concentrations
123
in a complex were 0.02, 0.05 and 0.1 µM. After sample preparation, 100 uL of solutions were
124
transferred into 96-well black plate. All measurements were recorded with fluorescence
ACS Paragon Plus Environment
7
Molecular Pharmaceutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 8 of 45
125
microplate reader (Fluoroscan Ascent FL). The excitation wavelength was 500 nm and the
126
excitation wavelength was 538 nm. Samples were shaken prior to every measurement. The first
127
measurement was recorded with no SOSG probe in order to determine whether RB or RB-1cat
128
emits fluorescence in this region. Both, RB and RB-1cat did not show any emission upon
129
excitation at 500 nm. Following the first measurement, SOSG was added to each well and the
130
fluorescence of SOSG without irradiation was checked. Next, the plate were immediately placed
131
under the Q.Light Pro Unit lamp equipped with a filter emitting visible light from 385 nm to 780
132
nm. All samples were irradiated and the fluorescence was measured in the course of irradiation
133
time, from 1 to 60 minutes.
134
2.2.2. Cell culture
135
Three murine basal cell carcinoma lines were kindly provided by Dr. Ervin Epstein (Children’s
136
Oakland Research Institute). ASZ, BSZ and CSZ cells were cultured in 154-CF mediumwith
137
antibiotics, 0.05 mM calcium and 2% chelexed, heat-inactivated FBS. Cells were maintained at
138
37°C in a humidified incubator and under a 5% CO2 atmosphere. After harvesting, cells were
139
counted using trypan blue exclusion assay for further experiments (Countess Automated Cell
140
Counter, Invitrogen). For harvesting the cells a 0.25% (w/v) trypsin–0.03% (w/v) EDTA solution
141
was used.
142
2.2.3. Cellular uptake
143
ASZ, BSZ and CSZ cell lines were seeded in 24-well plates and incubated for 24 hours in a
144
humified incubator under 5% CO2 atmosphere. Next, RB (10 µM) and RB-1cat were added to
145
the cells in 154 CF medium. The cells were incubated with the compounds up to 7 hours.
146
Following the incubation the compounds were discarded and cells were washed with DPBS
147
buffer. Next, the cells were detached using Trypsin-EDTA solution. Then, fresh culture medium
ACS Paragon Plus Environment
8
Page 9 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
148
was added to the cells and the samples were gently mixed and collected for measurements. For
149
estimating the cellular uptake, the fluorescence of the samples was measured using flow
150
cytometry (LSRII, Becton Dickinson). The excitation and the emission filters were 520 nm and
151
570 nm, respectively.
152
2.2.4. Photodynamic activity of RB and RB-1cat complex in vitro
153
To measure cytotoxicity cells were seeded in 96-well plates at density 3 × 104 cells well−1.
154
After 24h incubation, the culture medium was aspirated from the wells. Then, 100 µL of free
155
photosensitizer (RB) or complex (RB-1cat) were added to the cells. All components were
156
prepared in fresh culture medium. RB was used at concentrations of 0.1, 0.25, 0.5 and 0.75 µM.
157
The molar ratio RB:1cat was 5:1, therefore the dendrimer was used at concentrations of 0.02,
158
0.05, 0.1 and 0.15 µM. The control cells were untreated, instead fresh culture medium was
159
added. Cells were incubated with components for 5 hours in 37°C. Then, the medium containing
160
tested components was replaced with fresh DPBS buffer and cells were irradiated with visible
161
light using a lamp emitting broad spectrum light equipped with a filter (Q.Light Pro Unit,
162
Q.Products AG, Switzerland). The filter used for photosensitizing RB emits visible light from
163
385 nm to 780 nm. The time of irradiation was 30 minutes. Immediately after irradiation DPBS
164
buffer was replaced with fresh culture medium and cells were incubated for 24 hours as post
165
PDT incubation. Then, cell viability was measured using MTT assay. MTT was added to the
166
wells at a concentration of 0.5 mg/mL and incubated in 37°C for 3 hours. The formazan crystals
167
were dissolved with DMSO and the absorbance was read at 570 nm on the PowerWave HT
168
Microplate Spectrophotometer (BioTek, USA). Also, the dark toxicity (without irradiation) of
169
RB, RB-1cat and 1cat was checked. The protocol of these experiments was identical but in this
170
case cells were not irradiated.
ACS Paragon Plus Environment
9
Molecular Pharmaceutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 10 of 45
171
2.2.5. Detection of apoptotic and necrotic cells after the irradiation
172
Annexin V-Fluorescein Isothiocyanate (FITC)/Sytox staining was used to determine apoptotic
173
and necrotic cells. The double staining method allows detecting apoptotic cells in which
174
phosphatydylserine is translocated to outer layer of the plasma membrane. Annexin V possesses
175
high affinity to phosphatydylserine. Apoptotic cells stained with Annexin V-FITC exclude
176
Sytox, and necrotic cells are permeable to Sytox. Thus, the double staining allows differentiating
177
between viable, apoptotic and necrotic cell populations. Cells were seeded in 12-well plates at
178
the density of 2.5 x 105 cells/well and incubated for 24 hours. Then, RB and RB-1cat were
179
added. The concentration of RB and 1cat was 0.25 µM and 0.05 µM, respectively. After 5 hours
180
incubation, cells were irradiated as it was described in the previous experiments. Next, cells were
181
washed with DPBS, detached and centrifuged at 2500 rpm. Then cells were suspended in 200 µL
182
of binding buffer (delivered by the producer) containing 4 µL of Annexin V-FITC and 0.2 µL of
183
Sytox. Samples were incubated for 15 min at 4°C in dark. Fluorescence intensity was measured
184
with a Becton Dickinson LSR II flow cytometer. Apoptotic and necrotic cells were used as
185
compensation controls. Apoptosis was induced using 80 µM camptothecin and necrosis was
186
induced using frozen ethanol (data not shown).
187
2.2.6. Reactive oxygen species
188
We used H2DCFDA molecular probe (2’, 7’- dichlorodihydrofluorescein diacetate, Molecular
189
Probes™) in order to investigate the intracellular production of ROS. Cells were seeded in 96-
190
well plates at density 3 × 104 cells well−1and solutions of RB, RB1-cat and 1cat were added. The
191
concentration of free and complexated RB was 0.25 µM and 1cat concentration was 0.05 µM.
192
DPBS was used as a control. Cells were incubated with components for 5 hours at 37°C in a
193
humified atmosphere containing 5% CO2. After washing the cells with DPBS, solution of 2 µM
ACS Paragon Plus Environment
10
Page 11 of 45
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
194
H2DCFDA in DPBS was added to each wells and plates were incubated for 15 min in dark.
195
Next, the cells were washed with DPBS and 100 µL of DPBS was added. 485/530 nm
196
fluorescence of DCF was measured as a background using BIOTEK PowerWave HT Microplate
197
reader (Biotek). Then cells were irradiated for 30 min and the fluorescence was measured
198
immediately after irradiation. Every measurement was corrected by subtraction of the
199
background fluorescence intensity.
200
2.2.7. Statistical analysis
201
Statistical analysis was performed using Sigma Plot version 12.5 (Systat Software, USA).
202
Results are presented as a mean ± SD of three independent experiments. One-way analysis of
203
variance (ANOVA) was used for testing statistical differences between groups followed by post-
204
hoc Tukey test. A P-value of